Guidelines for the treatment of GPP in Japan (translated into English in 2018) recommend biologics for the treatment of GPP in Japan, including TNF inhibitors and IL inhibitors, as well as non‐biologic systemic therapies, such as etretinate, methotrexate, and cyclosporin for the symptoms of skin disease.3 Here, TNF is linked to psoriasis 14, pustular.